XML 195 R55.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings per share (Tables)
12 Months Ended
Sep. 30, 2020
Earnings per share  
Schedule of earnings per share

 

 

2020

 

2019

 

2018

$m

    

Basic

    

Diluted

    

Basic

    

Diluted

    

Basic

    

Diluted

Net profit attributable to shareholders

 

2,290

 

2,290

 

6,784

 

6,784

 

8,095

 

8,095

Adjustment for RSP dividends1

 

(2)

 

(2)

 

(6)

 

(6)

 

(5)

 

 —

Adjustment for potential dilution:

 

 

 

 

 

 

 

 

 

  

 

  

Distributions to convertible loan capital holders2

 

 —

 

 —

 

 —

 

290

 

 —

 

283

Adjusted net profit attributable to shareholders

 

2,288

 

2,288

 

6,778

 

7,068

 

8,090

 

8,378

Weighted average number of ordinary shares (millions)

 

 

 

 

 

 

 

 

 

  

 

  

Weighted average number of ordinary shares on issue

 

3,595

 

3,595

 

3,456

 

3,456

 

3,414

 

3,414

Treasury shares (including RSP share rights)1

 

(5)

 

(5)

 

(6)

 

(6)

 

(8)

 

(8)

Adjustment for potential dilution:

 

 

 

 

 

 

 

 

 

  

 

  

Share-based payments

 

 —

 

 1

 

 —

 

 1

 

 —

 

 3

Convertible loan capital2

 

 —

 

 —

 

 —

 

278

 

 —

 

232

Adjusted weighted average number of ordinary shares

 

3,590

 

3,591

 

3,450

 

3,729

 

3,406

 

3,641

Earnings per ordinary share (cents)

 

63.7

 

63.7

 

196.5

 

189.5

 

237.5

 

230.1

 


1.

RSP is explained in Note 33. Some shares under the RSP have not vested and are not outstanding ordinary shares but do receive dividends. These RSP dividends are deducted to show the profit attributable to ordinary shareholders. Shares under the RSP were antidilutive in 2020 and 2019, but were dilutive in 2018.

2.

The Group has issued convertible loan capital which may convert into ordinary shares in the future (refer to Note 19 for further details). These convertible loan capital instruments are potentially dilutive instruments, and diluted EPS is therefore calculated as if the instruments had been converted at the beginning of the year or, if later, the instruments’ issue date. In 2020, all convertible loan capital instruments were antidilutive, but were dilutive in 2019 and 2018.